Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

"We are pleased to report that this pharmaceutical company recently ordered additional Brilacidin for further testing. We interpret this as a positive sign and remain optimistic about this application for Brilacidin."

What kind of testing could they be doing with a drug that has yet to be approved? Might it be related to how its physical properties interact with those of the device?

This comment refers to just the device itself, right?
"1) the pharma bears the entire cost of development and clinical testing which would be in the terms of the MTA, 2) all risk for development would then be born by the pharma"

Brilacidin would presumably have been approved separately, so CTIX wouldn't benefit from that development and clinical testing except to the extent that the company would be compensated for providing or licensing the drug itself if the device was approved. That's the "several advantages for CTIX".